Animol Discovery

Animol Discovery focuses on developing innovative veterinary medicines through its proprietary drug discovery technology. The company specializes in creating small molecule active pharmaceutical ingredients tailored for the unique needs of veterinary patients. Utilizing a technology platform built on DNA-encoded chemicals, Animol enables accelerated ultra-high throughput screening processes, allowing for the simultaneous evaluation of target and anti-target activities. This approach aims to streamline the discovery of effective treatments for pets, addressing a significant need in the animal health industry. Led by a team of experts with extensive experience in bringing veterinary drugs to market, Animol is committed to advancing the field of veterinary medicine.